Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2αA) Is Inhibited by Tumor Necrosis Factor-α

This publication has 46 references indexed in Scilit:

• Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-κB
  Annals of the Rheumatic Diseases, 2000
• The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function
  Journal of Biological Chemistry, 2000
• Identification and Expression of a Novel 3′-Exon of Mouse Runx1/Pebp2αB/Cbfa2/AML1 Gene
  Biochemical and Biophysical Research Communications, 2000
• Pathogenesis of bone erosions in rheumatoid arthritis
  Current Opinion in Rheumatology, 2000
• Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte Maturation
  Journal of Bone and Mineral Research, 1999
• Multilineage Potential of Adult Human Mesenchymal Stem Cells
  Science, 1999
• Expression of the PEBP2αA/AML3/CBFA1 Gene is Regulated by BMP4/7 Heterodimer and Its Overexpression Suppresses Type I Collagen and Osteocalcin Gene Expression in Osteoblastic and Nonosteoblastic Mesenchymal Cells
  Bone, 1998
• The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
  Journal of Bone and Mineral Research, 1997
• Expression of cell growth and bone phenotypic genes during the cell cycle of normal diploid osteoblasts and osteosarcoma cells
  Journal of Cellular Biochemistry, 1994
• Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women
  Journal of Bone and Mineral Research, 1990